UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Journal of infectious diseases, ISSN 0022-1899, 2017, Volume 216, Issue suppl_3, pp. S436 - s444
Aspergillus fumigatis | Aspergillus | epidemiology | treatment | fumigatis | azole-esistant aspergillosis | cyp51 mutations | non cyp51 mutations | Azole-resistant aspergillosis | resistance mechanisms | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antifungal Agents - pharmacology | Aspergillus fumigatus - drug effects | Invasive Pulmonary Aspergillosis - drug therapy | Bronchitis - epidemiology | Humans | Cytochrome P-450 Enzyme System - metabolism | Tandem Repeat Sequences | Fungal Proteins - genetics | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Invasive Pulmonary Aspergillosis - diagnosis | Bronchitis - diagnosis | Triazoles - pharmacology | Point Mutation | Bronchitis - diet therapy | Cytochrome P-450 Enzyme System - genetics | Drug Resistance, Fungal | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Aspergillosis, Allergic Bronchopulmonary - epidemiology | Fungal Proteins - metabolism | Invasive Pulmonary Aspergillosis - epidemiology | Index Medicus | Abridged Index Medicus
Journal Article
Journal de mycologie médicale, ISSN 1156-5233, 04/2020, Volume 30, Issue 1, pp. 100915 - 100915
Journal Article
Fungal genetics and biology, ISSN 1087-1845, 09/2015, Volume 82, pp. 69 - 84
Septoria tritici | Mycosphaerella graminicola | Dimorphic fungi | Fatty acids | Cytochrome P450 | CYP51 | WT, wild-type | CPR, cytochrome P450 reductase | Regular | DPI, days post inoculation | STB, Septoria tritici blotch | FPKM, fragments per kilobase per million mapped fragments | HPLC, high pressure liquid chromatography | FAME, fatty acid methyl ester | RNA-seq, RNA sequencing | b5, cytochrome b5 | LCB, sphingolipid long chain base | CBR, cytochrome b5 reductase | GC–MS, gas chromatography–mass spectrometry | CYP, cytochrome P450
Journal Article
Infection and drug resistance, ISSN 1178-6973, 08/2017, Volume 10, pp. 249 - 259
Candida albicans | Aspergillus | Candida auris | Azoles | Intrinsic resistance | Acquired resistance | Echinocandins | Investigational antifungals | Non-albicans Candida species | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Science & Technology | Complications and side effects | Drug resistance in microorganisms | Prognosis | Antifungal agents | Mycoses | Dosage and administration | Research | Drug therapy | Enzymes | Ergosterol | Fluconazole | Toxicity | Antimicrobial agents | Fungal infections | Patients | Chemotherapy | Side effects | Testing laboratories | Trends | Mutation | Species | echinocandins | investigational antifungals | azoles | Candida
Journal Article
Emerging infectious diseases, ISSN 1080-6040, 10/2018, Volume 24, Issue 10, pp. 1889 - 1897
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Aspergillus fumigatus - drug effects | Ergosterol - metabolism | Humans | Fungal Proteins - genetics | Aspergillus fumigatus - genetics | Azoles - pharmacology | DNA, Fungal | Genotyping Techniques | Microbial Sensitivity Tests | Genome, Fungal | Aspergillus fumigatus - isolation & purification | Aspergillosis - microbiology | Cytochrome P-450 Enzyme System - genetics | Genes, Fungal | Aspergillus fumigatus - metabolism | Polymorphism, Single Nucleotide | Mutation | Drug Resistance, Fungal | Hydroxymethylglutaryl CoA Reductases - genetics | Microsatellite Repeats | Physiological aspects | Genetic aspects | Chromosomal proteins | Phytosterols | Index Medicus | azole resistance | Isolates with HMG-CoA Reductase Mutation in | Japan | non-cyp51A | Research | Non | Azole-Resistant | Gene Encoding | Hmg1 | mutation | HMG-CoA reductase | fungi | antimicrobial resistance | drug resistance | Aspergillus fumigatus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2004, Volume 363, Issue 9427, pp. 2128 - 2135
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Adrenals. Adrenal axis. Renin-angiotensin system (diseases) | Biological and medical sciences | Endocrinopathies | Non tumoral diseases. Target tissue resistance. Benign neoplasms | Medical sciences | Cytochrome P-450 Enzyme System - chemistry | Humans | Adolescent | Adrenal Hyperplasia, Congenital - metabolism | Child, Preschool | Cytochrome P-450 Enzyme System - genetics | Androgens - biosynthesis | Female | Male | Adrenal Hyperplasia, Congenital - genetics | Mutation | Amino Acid Substitution | Pathology | Androgens | Medical disorders | Genomics | Girls | Cytochrome | Steroid 21-hydroxylase | Enzyme activity | Pathogenesis | Oxidoreductase | Hyperplasia | Parents | Electron transfer | Heterozygotes | Biosynthesis | Proteins | Design | Synthesis | Enzymatic activity | Metabolites | Children | NADP | Deoxyribonucleic acid--DNA | Age | Enzymes | Data analysis | Genitalia | Fetuses | Hydroxylase | Patients | Molecular chains | Studies | Pregnancy | Cytochrome c | Testosterone | Cysts | Steroids | Reductase | Index Medicus | Abridged Index Medicus
Journal Article
Current pharmaceutical design, ISSN 1381-6128, 2013, Volume 19, Issue 14, pp. 2561 - 2573
Galactofuranose | Inhibitors | Eukaryotic pathogens | Flavoenzyme | Enzyme drug target | Galactopyranose | Non-redox reaction | UDP-galactopyranose mutase | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Humans | Virulence | Molecular Sequence Data | Drug Discovery - methods | Protozoan Infections - drug therapy | Eukaryota - pathogenicity | Protozoan Infections - parasitology | Enzyme Inhibitors - chemistry | Intramolecular Transferases - chemistry | Eukaryota - enzymology | Binding Sites | Aspergillosis - drug therapy | Amino Acid Sequence | Enzyme Inhibitors - pharmacology | Models, Molecular | Enzyme Inhibitors - therapeutic use | Intramolecular Transferases - metabolism | Sequence Alignment | Animals | High-Throughput Screening Assays | Intramolecular Transferases - antagonists & inhibitors | Aspergillosis - microbiology | Bacteria - enzymology | Eukaryota - drug effects | Protein Conformation | Bacteria - pathogenicity | Amino acid sequence
Journal Article
Future microbiology, ISSN 1746-0913, 2014, Volume 9, Issue 5, pp. 697 - 711
environment | resistance mechanism | Aspergillus fumigatus | non-cyp51A mutation | aspergillosis | Life Sciences & Biomedicine | Microbiology | Science & Technology | Aspergillus fumigatus - drug effects | Fungal Proteins - biosynthesis | Humans | Voriconazole - therapeutic use | Azoles - therapeutic use | Drug Resistance, Fungal - genetics | Fungal Proteins - genetics | Aspergillus fumigatus - genetics | Cholesterol - metabolism | Aspergillus fumigatus - pathogenicity | Antifungal Agents - therapeutic use | Itraconazole - therapeutic use | Microbial Sensitivity Tests | Cytochrome P-450 Enzyme System - biosynthesis | Cytochrome P-450 Enzyme System - genetics | Mutation | Aspergillosis - drug therapy | Triazoles - therapeutic use
Journal Article
Biomedicine & pharmacotherapy, ISSN 0753-3322, 2016, Volume 84, pp. 1019 - 1028
Internal Medicine | Medical Education | Pyridinyl carboxamide derivative | Oxaliplatin | Synergism | Lung cancer | Apoptosis | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Amides - pharmacology | Carcinoma, Non-Small-Cell Lung - pathology | Cell Survival - drug effects | Lung Neoplasms - drug therapy | Apoptosis - drug effects | Humans | Models, Molecular | Lung Neoplasms - pathology | Structure-Activity Relationship | Organoplatinum Compounds - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Drug Synergism | Cell Cycle Checkpoints - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Molecular Structure | Pyridines - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Antimitotic agents | Respiratory agents | Drug therapy, Combination | Lung cancer, Non-small cell | Antineoplastic agents | Analysis | Index Medicus
Journal Article